Puthen V. Jithesh - Concepedia

Author

Puthen V. Jithesh

Also Known As

Arash Rafii Tabrizi, Fathima Abubacker, Herb Schellhorn, J. Puthen, Jithesh P, Jithesh Puthen, Jithesh V Puthen, Jithesh V. Puthen, Jithesh, Puthen, Lotfi Chouchane

199

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Sidra Medical and Research Center Hamad bin Khalifa University University of Liverpool Weill Cornell Medical College in Qatar Qatar Foundation

About

Puthen V. Jithesh is an author at Sidra Medical and Research Center specializing in medicine, cell biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	361
2	Cell Biology	8	8	232
3	Engineering	3	3	62
4	Biostatistics	2	2	34
5	Data Science	1	1	18

Puthen V. Jithesh

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Depletion of Human DNA in Spiked Clinical Specimens for Improvement of Sensitivity of Pathogen Detection by Next-Generation Sequencing Mohammad R. Hasan, Arun Rawat, Patrick Tang, Journal of Clinical Microbiology	2016	246
ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer Sandra Van Schaeybroeck, Murugan Kalimutho, Philip D. Dunne, Cell Reports	2014	106
The epigenetic landscape of oral squamous cell carcinoma Puthen V. Jithesh, Janet M. Risk, Andrew Schache, British Journal of Cancer	2013	101
Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway Lana McClements, Anita Yakkundi, Angelos Papaspyropoulos, Clinical Cancer Research	2013	78
Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome Xiao‐Fei Kong, Lisa Worley, Darawan Rinchai, Journal of Clinical Immunology Down SyndromeAutoimmune DiseaseGenetic DisorderGeneticsPathogenesis	2020	74
Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy Wendy L. Allen, Philip D. Dunne, Simon S. McDade, JCO Precision Oncology	2018	69
Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer Leanne Stevenson, Wendy L. Allen, Richard Turkington, Clinical Cancer Research	2012	63
FKBPL Regulates Estrogen Receptor Signaling and Determines Response to Endocrine Therapy Hayley D. McKeen, Christopher Byrne, Puthen V. Jithesh, Cancer Research Breast OncologyImmunologyEndocrine TherapyDetermines ResponseCell Signaling	2010	47
A population study of clinically actionable genetic variation affecting drug response from the Middle East Puthen V. Jithesh, Mohammed Abuhaliqa, Najeeb Syed, npj Genomic Medicine	2022	47
A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal Cancer Wendy L. Allen, Leanne Stevenson, Vicky M. Coyle, Molecular Cancer Therapeutics	2011	41

Page 1